<DOC>
	<DOC>NCT00950690</DOC>
	<brief_summary>Efficacy data was not collected or analyzed. This study did assess safety and tolerability of Xalatan.</brief_summary>
	<brief_title>Efficacy and Tolerability of Xalatan in Patients</brief_title>
	<detailed_description>- Efficacy data not collected or analyzed - Safety and tolerability of Xalatan assessed NA</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Patient with ocular hypertension at least 22mg Hg Patient must be over 18 years old None listed in the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>observational safety study</keyword>
</DOC>